Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride

BACKGROUND/AIMS: Cystinosis is a rare, autosomal recessive disorder causing defective transport of cystine out of lysosomes. Cystadrops (0.55% cysteamine hydrochloride in viscous solution) has been used on a named-patient basis to treat the accumulation of cystine crystals in the cornea in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hong, Labbé, Antoine, Baudouin, Christophe, Plisson, Celine, Giordano, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077218/
https://www.ncbi.nlm.nih.gov/pubmed/32593979
http://dx.doi.org/10.1136/bjophthalmol-2020-316450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077218/
https://www.ncbi.nlm.nih.gov/pubmed/32593979
http://dx.doi.org/10.1136/bjophthalmol-2020-316450

Ejemplares similares